Latest Headlines

Latest Headlines

Novo Nordisk says all its manufacturing plants will run on renewable electricity by 2020

Novo Nordisk, the Danish maker of insulin, said all of its global manufacturing facilities will run on electricity generated from renewable sources by 2020.

Some production resumes at Strides Shasun facility following fire that killed one

Strides Shasun has resumed limited production at its Cuddalore API plant in India following a fire last week that killed one worker.

South Africa's Ascendis picks up manufacturing facility in $24.6M deal for Akacia

South Africa-based Ascendis Health has acquired a 23,000-square-foot manufacturing facility as part of its $24.6 million deal for the pharmaceutical business of Akacia Healthcare.

A Pfizer-Allergan marriage could prove hard on their manufacturing networks

Pfizer and Allergan are reportedly close to announcing a merger that would turn the two into the largest of the Big Pharma companies, Bloomberg has reported. They also would have the largest manufacturing network with possibly more than 100 production facilities. But Pfizer's acquisition record suggests that number would shrink significantly postmerger as it looked for ways to cut costs to pay for the massive deal.

Baxalta Singapore plant gets FDA OK to produce Advate hemophilia product

The hemophilia A treatment Advate is the cornerstone to the future of Baxalta, the company that was created when Baxter International spun off its drug operations in July. Now the newbie will be able to produce more of the product at a plant in Singapore it opened just last year.

Top Novartis exec in India says two plants warned by FDA completing remediation

Novartis India Managing Director Ranjit Shahani told India's PTI that the drugmaker expects upgrades at two Sandoz plants that were issued a warning letter by the FDA to soon be back to full production.

Four Roche plants go up for sale in move to more high-potency, targeted drugs

Roche will close four plants around the world and lay off 1,200 people as it moves to new technology for manufacturing small molecule drugs. It says it will build a late-stage technical development and launch facility in Switzerland for targeted, high-potency drugs.

Cellular Biomedicine adds facility in China that will help with CAR-T processing

Cellular Biomedicine, a biotech working in the hot new area of treating cancer by creating CAR-T cells, has opened another facility in China.

CEO says Sanofi will 'reshape' manufacturing but is short on specifics

For several months, Sanofi's new CEO Olivier Brandicourt has indicated that one part of his turnaround plan for the French drugmaker would involve significant changes in manufacturing to make it more efficient. And while the CEO told investors Friday that he would be looking for $1.6 billion in cost cuts in the next three years, and that some would come from a "reshape" of the manufacturing network, he was short on details about how that might play out.

Almac expanding in U.K., investing $24M in Charnwood tech park

CDMO Almac is taking over some facilities abandoned by AstraZeneca in the U.K. some years back and will build them out to expand its own formulation and manufacturing operations.